In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
The first ever ‘digital’ pill with a built-in sensor to track compliance has been approved by the FDA, 19 months after being rejected by the agency over safety concerns. Abilify MyCite combines Otsuka ...
Tardive dyskinesia is a movement disorder often caused by antipsychotic drugs. Ingrezza and Austedo are FDA-approved medicines that can help reverse symptoms of tardive dyskinesia. Tardive dyskinesia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback